Lifesprout

Lifesprout

Developing products for aesthetic and regenerative medicine. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD176—264m (Dealroom.co estimates Apr 2020.)
Baltimore Maryland (HQ)
  • Edit

Recent News about Lifesprout

Edit
More about Lifesproutinfo icon
Edit

LifeSprout, founded in September 2015 by leading scientists and surgeons at Johns Hopkins University, specializes in developing next-generation soft tissue restoration products for the aesthetic and reconstructive markets. The company focuses on creating revolutionary solutions for soft tissue replacement and regeneration, utilizing recent breakthroughs in materials science. LifeSprout's products are designed to look and behave like natural tissues, offering minimal downtime and superior results for patients suffering from soft tissue losses due to aging, cancer, and metabolic diseases. The company's business model revolves around research and development, targeting both aesthetic and medical clients, including individuals seeking cosmetic enhancements and patients requiring reconstructive procedures. LifeSprout generates revenue through the sale of its innovative products to healthcare providers and clinics. The company operates in the highly specialized market of regenerative medicine and aesthetic treatments, aiming to provide best-in-class solutions that enhance form and function.

Keywords: soft tissue restoration, aesthetic medicine, regenerative medicine, materials science, tissue replacement, reconstructive surgery, minimal downtime, advanced technology, healthcare innovation, patient-centric.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.